"UPMC Magee-Womens Hospital is a Maternity Hospital located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, Magee-Womens Hospital of UPMC conducted 204 clinical trials. In the 10-year time frame, 204 clinical trials started and 122 clinical trials were completed, i.e. on average, 59.8% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 67 clinical trials were completed. i.e. 103.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Magee-Womens Hospital of UPMC" #1 sponsor was "University of Pittsburgh" with 75 trials, followed by "National Cancer Institute (NCI)" with 47 trials sponsored, "The George Washington University Biostatistics Center" with 18 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored and "Alliance for Clinical Trials in Oncology" with 15 trials sponsored. Other sponsors include 226 different institutions and companies that sponsored additional 128 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magee-Womens Hospital of UPMC" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 35 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "National Institutes of Health (NIH)" with 13 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials as a collaborator. Other collaborators include 269 different institutions and companies that were collaborators in the rest 171 trials.

According to Clinical.Site data, the most researched conditions in "Magee-Womens Hospital of UPMC" are "Breast Cancer" (30 trials), "Ovarian Cancer" (18 trials), "Pregnancy" (18 trials), "Metastatic Breast Cancer" (13 trials) and "Contraception" (11 trials). Many other conditions were trialed in "Magee-Womens Hospital of UPMC" in a lesser frequency.

Most popular intervention types in "Magee-Womens Hospital of UPMC" are "Drug" (256 trials), "Other" (115 trials), "Procedure" (53 trials), "Biological" (47 trials) and "Device" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Placebo" (38 trials), "Paclitaxel" (36 trials), "Carboplatin" (32 trials) and "Quality-of-Life Assessment" (32 trials). Other intervention names were less common.

The vast majority of trials in "Magee-Womens Hospital of UPMC" are 257 trials for "Female" genders, 132 trials for "All" genders and 10 trials for "Male" genders.

Currently, there are 142 active trials in "Magee-Womens Hospital of UPMC". 1 are not yet recruiting, 64 are recruiting, 74 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 191 completed trials in Magee-Womens Hospital of UPMC, 5 suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in Magee-Womens Hospital of UPMC, 34 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 140 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 67 trials that are defined as “Not Applicable".